Literature DB >> 11115164

Antibodies to molluscum contagiosum virus in the general population and susceptible patients.

T Watanabe1, K Nakamura, M Wakugawa, A Kato, Y Nagai, T Shioda, A Iwamoto, K Tamaki.   

Abstract

BACKGROUND: Since many attempts to cultivate molluscum contagiosum virus (MCV) in vitro have been unsuccessful, it is difficult to prepare a large quantity of antigens. To assess the seroprevalence of antibodies against MCV in 508 subjects with or without clinical MCV infection, a truncated recombinant protein from open-reading frame MC133L was synthesized using Sendai virus expression system and applied to enzyme-linked immunosorbent assay as an antigen. OBSERVATIONS: Antibodies to MCV were present in 7 (58%) of 12 patients with molluscum contagiosum, 7 (6%) of 108 healthy controls, 7 (9%) of 76 with atopic dermatitis, and 7 (18%) of 39 patients with systemic lupus erythematosus, although no clinical MCV infection was observed in the latter 3 groups. Of 7 human immunodeficiency virus (HIV)-positive patients with molluscum contagiosum, 1 (14%) was antibody positive, compared with 5 (2%) of 266 HIV-positive patients without molluscum contagiosum. Serum samples from patients with atopic dermatitis and systemic lupus erythematosus showed a higher reactivity (P<.001) than those from healthy controls, while serum samples from HIV-positive subjects showed a lower reactivity (P<. 001).
CONCLUSION: The humoral immune response to MCV is usually confined to patients with molluscum contagiosum and may be affected by the immunological condition of the host.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115164     DOI: 10.1001/archderm.136.12.1518

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-κB activation by interacting with the IκB kinase complex.

Authors:  Crystal M H Randall; Janet A Jokela; Joanna L Shisler
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  Pediatric molluscum contagiosum: optimal treatment strategies.

Authors:  Nanette Silverberg
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  Inhibition of interferon gene activation by death-effector domain-containing proteins from the molluscum contagiosum virus.

Authors:  Crystal M H Randall; Sunetra Biswas; Catherine V Selen; Joanna L Shisler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

4.  Seroprevalence of Molluscum contagiosum virus in German and UK populations.

Authors:  Subuhi Sherwani; Laura Farleigh; Nidhi Agarwal; Samantha Loveless; Neil Robertson; Eva Hadaschik; Paul Schnitzler; Joachim Jakob Bugert
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.